You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
|
|---|---|
| Published in |
CNS Drugs, May 2019
|
| DOI | 10.1007/s40263-019-00624-4 |
| Pubmed ID | |
| Authors |
James W. Wheless, Dennis Dlugos, Ian Miller, D. Alexander Oh, Neha Parikh, Steven Phillips, J. Ben Renfroe, Colin M. Roberts, Isra Saeed, Steven P. Sparagana, Jin Yu, Maria Roberta Cilio |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| Canada | 1 | 20% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Scientists | 1 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 199 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 34 | 17% |
| Researcher | 20 | 10% |
| Student > Master | 14 | 7% |
| Student > Ph. D. Student | 12 | 6% |
| Other | 11 | 6% |
| Other | 25 | 13% |
| Unknown | 83 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 12% |
| Neuroscience | 12 | 6% |
| Biochemistry, Genetics and Molecular Biology | 9 | 5% |
| Nursing and Health Professions | 6 | 3% |
| Other | 27 | 14% |
| Unknown | 91 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2022.
All research outputs
#617,428
of 25,837,817 outputs
Outputs from CNS Drugs
#44
of 1,403 outputs
Outputs of similar age
#13,607
of 365,480 outputs
Outputs of similar age from CNS Drugs
#1
of 16 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,403 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.